Evidence map›Paper›PMID 36158929›Full record

ArticleThe Pan African medical journal2022

Evaluation of integrated disease surveillance and response (IDSR) and early warning and response network (EWARN) in South Sudan 2021.

John Rumunu, Joseph Francis Wamala, Robert Sakaya, Sheila Baya Konga, Alice Lado Igale, Abraham Abenego Adut, Scopas Korsuk Lonyik, Robert Martin Lasu, Rose Dagama Kaya, Guyo Guracha and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

John RumunuDoctoral Program in Global Health, Humanitarian Aid and Disaster Medicine, Universita Del Pemonte Orientale and Vrije University Brussel, Juba, South Sudan.
Joseph Francis WamalaWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Robert SakayaIndependent Consultant, Juba, South Sudan.
Sheila Baya KongaWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Alice Lado IgaleWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Abraham Abenego AdutWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Scopas Korsuk LonyikWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Robert Martin LasuWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Rose Dagama KayaWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Guyo GurachaWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Peter NsubugaGlobal Public Health Solutions, Juba, South Sudan.
Fabian NdenzakoWorld Health Organization Country Office for South Sudan, Juba, South Sudan.
Ambrose Otau TalisunaWorld Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.
University of Juba · SSWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

Introduction: South Sudan has been implementing the Integrated Disease Surveillance and Response (IDSR) strategy since 2006, along with Early Warning and Alert Response and Network (EWARN). The IDSR/EWARN stakeholders commissioned an independent evaluation to establish performance at national, state, county, health facility, and community levels in the first half of 2021. Methods: the evaluation was conducted between June and September 2021 (during the COVID-19 pandemic) and was based on the World Health Organization (WHO) protocols for monitoring and evaluating communicable disease surveillance and response systems and the guidelines for evaluating EWARN. Results: integrated disease surveillance and response/early warning and alert response and network indicator data showed improving timeliness and completeness from the beginning of 2021 to week 16 and then a slight depression of timeliness by week 32, while completeness remained high. Event-based surveillance was active at the beginning of 2021 and in week 32. However, there was inadequate sample collection to investigate acute watery diarrhea, bloody diarrhea, and acute jaundice syndrome alerts. Respondents in all cadres had substantial experience working in IDSR/EWARN. All respondents performed the various IDSR/EWARN tasks and duties as expected, but needed more resources and training. Conclusion: while IDSR/EWARN is performing relatively well, confirmation of priority diseases by the laboratories needs to be strengthened. Health facilities need more regular supervision from the higher levels. Community health workers need more training on IDSR/EWARN. The whole IDSR/EWARN system needs more resources, particularly for communication and transport and to confirm priority diseases. Staff at all levels requested more training in IDSR/EWARN.

Indexed as

Communicable Disease ControlCOVID-19DiarrheaDisease OutbreaksHumansPandemicsPopulation SurveillanceSouth SudandetectDisease surveillancefeedbackpriority diseasesresponse

Identifiers

PMID36158929
PMCPMC9474832
OpenAlexW4297252612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.